James E Galvin

No ORCID on file · 2 papers in corpus · active 2021-2022

Study types

  • other 1

Condition tags

  • endometriosis 1
2022
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis
·doi:10.1101/2022.04.01.22273253

ABSTRACT Objective To update a recently published analysis exploring the causal association between positron emission tomography (PET)-measured change in brain β-amyloid plaque and cognitive decline in patients with Alzheimer’s disease (AD)…

other 2021
Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's
Contemporary clinical trials ·doi:10.1016/j.cct.2021.106488

The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide …